The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Pharmacology and Biological Efficacy of a Recombinant, Humanized, Single-Chain Antibody C5 Complement Inhibitor in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass
Open accessAbstract
Background —Cardiopulmonary bypass (CPB) induces a systemic inflammatory response that causes substantial clinical morbidity. Activation of complement during CPB contributes significantly to this inflammatory process. We examined the capability of a novel therapeutic complement inhibitor to prevent pathological complement activation and tissue injury in patients undergoing CPB. Methods and Results —A humanized, recombinant, single-chain antibody specific for human C5, h5G1.1-scFv, was intravenously administered in 1 of 4 doses ranging from 0.2 to 2.0 mg/kg before CPB. h5G1.1-scFv was found to be safe and well tolerated. Pharmacokinetic analysis revealed a sustained half-life from 7.0 to 14.5 hours. Pharmacodynamic analysis demonstrated significant dose-dependent inhibition of complement hemolytic activity for up to 14 hours at 2 mg/kg. The generation of proinflammatory complement byproducts (sC5b-9) was effectively inhibited in a dose-dependent fashion. Leukocyte activation, as measured by surface expression of CD11b, was reduced ( P <0.05) in patients who received 1 and 2 mg/kg. There was a 40% reduction in myocardial injury (creatine kinase–MB release, P =0.05) in patients who received 2 mg/kg. Sequential Mini-Mental State Examinations (MMSE) demonstrated an 80% reduction in new cognitive deficits ( P <0.05) in patients treated with 2 mg/kg. Finally, there was a 1-U reduction in postoperative blood loss ( P <0.05) in patients who received 1 or 2 mg/kg. Conclusions —A single-chain antibody specific for human C5 is a safe and effective inhibitor of pathological complement activation in patients undergoing CPB. In addition to significantly reducing sC5b-9 formation and leukocyte CD11b expression, C5 inhibition significantly attenuates postoperative myocardial injury, cognitive deficits, and blood loss. These data suggest that C5 inhibition may represent a novel therapeutic strategy for preventing complement-mediated inflammation and tissue injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Complement and the damaging effects of cardiopulmonary bypass
Kirklin, J. K., Westaby, S., Blackstone, E. H., Kirklin, J. W., Chenoweth, D. E., & Pacifico, A. D. (1983) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)39061-0 · Cited by 1,325
Chenoweth, D. E., Cooper, S. W., Hugli, T. E., Stewart, R. W., Blackstone, E. H., & Kirklin, J. W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198102263040901 · Cited by 1,146
Inflammatory Response to Cardiopulmonary Bypass
Wan, S., LeClerc, J.-L., & Vincent, J.-L. (1997) · Chest · doi:10.1378/chest.112.3.676 · Cited by 888
The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning.
Pugsley, W., Klinger, L., Paschalis, C., Treasure, T., Harrison, M., & Newman, S. (1994) · Stroke · doi:10.1161/01.str.25.7.1393 · Cited by 722
Myonecrosis After Revascularization Procedures
Califf, R. M., Abdelmeguid, A. E., Kuntz, R. E., Popma, J. J., Davidson, C. J., Cohen, E. A., Kleiman, N. S., Mahaffey, K. W., Topol, E. J., Pepine, C. J., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00506-8 · Cited by 552
C5A Anaphylatoxin and Its Seven Transmembrane-Segment Receptor
Gerard, C., & Gerard, N. P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.004015 · Cited by 416
Hall, R. I., Smith, M. S., & Rocker, G. (1997) · Anesthesia & Analgesia · doi:10.1097/00000539-199710000-00011 · Cited by 407
Vakeva, A. P., Agah, A., Rollins, S. A., Matis, L. A., Li, L., & Stahl, G. L. (1998) · Circulation · doi:10.1161/01.cir.97.22.2259 · Cited by 399
Self-citationInhibition of complement activity by humanized anti-C5 antibody and single-chain Fv
Thomas, T. C., Rollins, S. A., Rother, R. P., Giannoni, M. A., Hartman, S. L., Elliott, E. A., Nye, S. H., Matis, L. A., Squinto, S. P., & Evans, M. J. (1996) · Molecular Immunology · doi:10.1016/s0161-5890(96)00078-8 · Cited by 363
Self-citation
Cited by
Gorbet, M. B., & Sefton, M. V. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.01.023 · Cited by 1,347
ROLE OF C5A IN INFLAMMATORY RESPONSES
Guo, R.-F., & Ward, P. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115835 · Cited by 1,021
Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update
Paparella, D. (2002) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(01)01099-5 · Cited by 969
Novel strategies for the treatment of sepsis
Riedemann, N. C., Guo, R.-F., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 773
Myasthenia gravis: past, present, and future
Conti-Fine, B. M., Milani, M., & Kaminski, H. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29894 · Cited by 691
Pathophysiology, Clinical Manifestations, and Prevention of Ischemia-Reperfusion Injury
Collard, C. D., & Gelman, S. (2001) · Anesthesiology · doi:10.1097/00000542-200106000-00030 · Cited by 661
Self-citationInflammatory response to cardiopulmonary bypass
Levy, J. H., & Tanaka, K. A. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)04701-x · Cited by 583
Vascular ischaemia and reperfusion injury
Eltzschig, H. K., & Collard, C. D. (2004) · British Medical Bulletin · doi:10.1093/bmb/ldh025 · Cited by 456
Self-citationThe role of complement in biomaterial-induced inflammation
Nilsson, B., Ekdahl, K. N., Mollnes, T. E., & Lambris, J. D. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.06.020 · Cited by 431
Anticoagulation and Coagulation Management for ECMO
Oliver, W. C. (2009) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253209347384 · Cited by 357
Central nervous system injury associated with cardiac surgery
Newman, M. F., Mathew, J. P., Grocott, H. P., Mackensen, G. B., Monk, T., Welsh-Bohmer, K. A., Blumenthal, J. A., Laskowitz, D. T., & Mark, D. B. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69254-4 · Cited by 327
Mechanisms and attenuation of hemostatic activation during extracorporeal circulation
Despotis, G. J., Avidan, M. S., & Hogue, C. W. (2001) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(01)03211-8 · Cited by 258
Polyglycolic Acid-Induced Inflammation: Role of Hydrolysis and Resulting Complement Activation
Ceonzo, K., Gaynor, A., Shaffer, L., Kojima, K., Vacanti, C. A., & Stahl, G. L. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.301 · Cited by 209
Self-citation
Metadata
- Authors
- Fitch, J. C. K., Rollins, S., Matis, L., Alford, B., Aranki, S., Collard, C. D., Dewar, M., Elefteriades, J., Hines, R., Kopf, G., Kraker, P., Li, L., O’Hara, R., Rinder, C., Rinder, H., Shaw, R., Smith, B., Stahl, G., & Shernan, S. K.
- Venue
- Circulation
- Published
- 1999-12-21
- Volume
- 100
- Issue
- 25
- Pages
- 2499-2506
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2043167284
- Cited by
- 281
- References
- 37
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.